Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Alain Pluen"'
Autor:
Catriona McCallion, Anna D. Peters, Andrew Booth, Karen Rees-Unwin, Julie Adams, Raisa Rahi, Alain Pluen, Claire V. Hutchinson, Simon J. Webb, John Burthem
Publikováno v:
Blood Advances, Vol 3, Iss 14, Pp 2069-2081 (2019)
Abstract: CXC chemokine receptor 4 (CXCR4) is overexpressed by a broad range of hematological disorders, and its interaction with CXC chemokine ligand 12 (CXCL12) is of central importance in the retention and chemoprotection of neoplastic cells in th
Externí odkaz:
https://doaj.org/article/2507d194e7a244fc8e6f2e80527f29d0
Publikováno v:
المجلة العراقية للصيدلة, Vol 16, Iss 1, Pp 1-21 (2019)
Introduction: Cell penetrating peptides (CPPs) have been used in many areas of drug delivery for mediating the delivery of peptides, protein, DNA, siRNA and liposomes. Additionally they have shown an ability to overcome drug resistance in cells and e
Externí odkaz:
https://doaj.org/article/b4fca30f4bce48989def579d04f2c921
Autor:
Alina Kulakova, Dillen Augustijn, Inas El Bialy, Lorenzo Gentiluomo, Maria Laura Greco, Stefan Hervø-Hansen, Sowmya Indrakumar, Sujata Mahapatra, Marcello Martinez Morales, Christin Pohl, Marco Polimeni, Aisling Roche, Hristo L. Svilenov, Andreas Tosstorff, Matja Zalar, Robin Curtis, Jeremy P. Derrick, Wolfgang Frieß, Alexander P. Golovanov, Mikael Lund, Allan Nørgaard, Tarik A. Khan, Günther H. J. Peters, Alain Pluen, Dierk Roessner, Werner W. Streicher, Christopher F. van der Walle, Jim Warwicker, Shahid Uddin, Gerhard Winter, Jens Thostrup Bukrinski, Åsmund Rinnan, Pernille Harris
Publikováno v:
Molecular Pharmaceutics.
Autor:
Kara M. Buzza, Alain Pluen, Christopher Doherty, Tanaporn Cheesapcharoen, Gurdeep Singh, Ruth G. Ledder, Prem K. Sreenivasan, Andrew J. McBain
Publikováno v:
Buzza, K M, Pluen, A, Doherty, C, Cheesapcharoen, T, Singh, G, Ledder, R G, Sreenivasan, P K & Mcbain, A J 2023, ' Modulation of Biofilm Formation and Permeability in Streptococcus mutans During Exposure to Zinc Acetate ', Microbiology spectrum . https://doi.org/10.1128/spectrum.02527-22
The penetration of biofilms by antimicrobials is a potential limiting factor in biofilm control. This is relevant to oral health, where compounds used to control microbial growth and activities could also affect the permeability of dental plaque biof
Autor:
Robin Curtis, Maryam Shah, Shahid Uddin, Peter Davis, Daniel Corbett, C. F. van der Walle, Aisling Roche, Nicole Sibanda, Alain Pluen, Alfredo Lanzaro
Publikováno v:
Shah, M, Corbett, D, Lanzaro, A, Roche, A, Sibanda, N, Davis, P, Uddin, S, van der Walle, C F, Curtis, R & Pluen, A 2020, ' Micro-and macro-viscosity relations in high concentration antibody solutions ', European Journal of Pharmaceutics and Biopharmaceutics, vol. 153, 10.1016/j.ejpb.2020.06.007, pp. 211-221 . https://doi.org/10.1016/j.ejpb.2020.06.007
Molecular crowding in highly concentrated monoclonal antibody (mAb) solutions results in significant increases in viscosity, which complicates fill-finish steps and patient administration by subcutaneous injection. As viscosity measurements for optim
Autor:
Alain Pluen, Richard A. Bryce, John Burthem, Alexander P. Golovanov, Catriona McCallion, Fai A. Alkathiri
Publikováno v:
Alkathiri, F A, McCallion, C, Golovanov, A P, Burthem, J, Pluen, A & Bryce, R A 2019, ' Solvation of Pristine Graphene Using Amino Acids : A Molecular Simulation and Experimental Analysis ', The Journal of Physical Chemistry Part C: Nanomaterials, Interfaces and Hard Matter, vol. 123, no. 50, 10.1021/acs.jpcc.9b06648, pp. 30234-30244 . https://doi.org/10.1021/acs.jpcc.9b06648, https://doi.org/10.1021/acs.jpcc.9b06648
We explore the ability of amino acid solutions, of L-Trp, L-Tyr or L-Val, to solvate pristine graphene flakes in an aqueous environment, via atomistic molecular dynamics simulations and experimental characterization. In accord with previous theoretic
Autor:
Angela Thistlethwaite, Jim Warwicker, Karl Fisher, Reza Esfandiary, Alexander P. Golovanov, James Austerberry, Alain Pluen, Jeremy P. Derrick, Robin Curtis, Christopher F. van der Walle
Publikováno v:
Austerberry, J, Thistlethwaite, A, Fisher, K, Golovanov, A P, Pluen, A, Esfandiary, R, van der Walle, C F, Warwicker, J, Derrick, J P & Curtis, R 2019, ' Arginine to lysine mutations increase the aggregation stability of a single chain variable fragment through unfolded state interactions ', Biochemistry . https://doi.org/10.1021/acs.biochem.9b00367
Increased protein solubility is known to correlate with an increase in the proportion of lysine over arginine residues. Previous work has shown that the aggregation propensity of a single-chain variable fragment (scFv) does not correlate with its con
Publikováno v:
Iraqi Journal of Pharmacy. 16:1-21
Autor:
Shahid Uddin, Christin Pohl, Christopher F. van der Walle, Inas El Bialy, Jeremy P. Derrick, Andreas Tosstorff, Robin Curtis, Sujata Mahapatra, Werner Streicher, Dillen Augustijn, Aisling Roche, Alina Kulakova, Wolfgang Frieß, Åsmund Rinnan, Hristo L. Svilenov, Dierk Roessner, Lorenzo Gentiluomo, Sowmya Indrakumar, Alain Pluen, Gerhard Winter, Pernille Harris, Allan Nørgaard, Günther H.J. Peters, Maria Laura Greco, Marcello Martinez Morales, Tarik A. Khan
Publikováno v:
Molecular Pharmaceutics
Gentiluomo, L, Svilenov, H L, Augustijn, D, El Bialy, I, Greco, M L, Vitaliyivna Kulakova, A, Indrakumar, S, Mahapatra, S, Morales, M M, Pohl, C, Roche, A, Tosstorff, A, Curtis, R, Derrick, J P, Nørgaard, A, Khan, T A, Peters, G H J, Pluen, A, Rinnan, Å, Streicher, W W, van der Walle, C F, Uddin, S, Winter, G, Roessner, D, Harris, P & Frieß, W 2020, ' Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization ', Molecular Pharmaceutics, vol. 17, no. 2, pp. 426-440 . https://doi.org/10.1021/acs.molpharmaceut.9b00852
Gentiluomo, L, Svilenov, H L, Augustijn, D, El Bialy, I, Greco, M L, Kulakova, A, Indrakumar, S, Mahapatra, S, Morales, M M, Pohl, C, Roche, A, Tosstorff, A, Curtis, R, Derrick, J P, Nørgaard, A, Khan, T A, Peters, G H J, Pluen, A, Rinnan, Å, Streicher, W W, van der Walle, C F, Uddin, S, Winter, G, Roessner, D, Harris, P & Friess, W 2020, ' Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization ', Molecular Pharmaceutics, vol. 17, no. 2, pp. 426-440 . https://doi.org/10.1021/acs.molpharmaceut.9b00852
Gentiluomo, L, Svilenov, H L, Augustijn, D, El Bialy, I, Greco, M L, Vitaliyivna Kulakova, A, Indrakumar, S, Mahapatra, S, Morales, M M, Pohl, C, Roche, A, Tosstorff, A, Curtis, R, Derrick, J P, Nørgaard, A, Khan, T A, Peters, G H J, Pluen, A, Rinnan, Å, Streicher, W W, van der Walle, C F, Uddin, S, Winter, G, Roessner, D, Harris, P & Frieß, W 2020, ' Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization ', Molecular Pharmaceutics, vol. 17, no. 2, pp. 426-440 . https://doi.org/10.1021/acs.molpharmaceut.9b00852
Gentiluomo, L, Svilenov, H L, Augustijn, D, El Bialy, I, Greco, M L, Kulakova, A, Indrakumar, S, Mahapatra, S, Morales, M M, Pohl, C, Roche, A, Tosstorff, A, Curtis, R, Derrick, J P, Nørgaard, A, Khan, T A, Peters, G H J, Pluen, A, Rinnan, Å, Streicher, W W, van der Walle, C F, Uddin, S, Winter, G, Roessner, D, Harris, P & Friess, W 2020, ' Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization ', Molecular Pharmaceutics, vol. 17, no. 2, pp. 426-440 . https://doi.org/10.1021/acs.molpharmaceut.9b00852
Therapeutic protein candidates should exhibit favorable properties that render them suitable to become drugs. Nevertheless, there are no well-established guidelines for the efficient selection of proteinaceous molecules with desired features during e
Autor:
Alain Pluen, Christopher F. van der Walle, Robin Curtis, Katie Day, Maryam Shah, Zahra Rattray, Shahid Uddin
Publikováno v:
Shah, M, Rattray, Z, Day, K, Uddin, S, Curtis, R, Van Der Walle, C F & Pluen, A 2017, ' Evaluation of Aggregate and Silicone-oil Counts in Pre-filled Siliconized Syringes : An orthogonal study characterising the entire subvisible size range ', International Journal of Pharmaceutics, vol. 519, no. 1-2, pp. 58-66 . https://doi.org/10.1016/j.ijpharm.2017.01.015
Characterisation of particulates in therapeutic monoclonal antibody (mAb) formulations is routinely extended to the sub-visible size-range (0.1–10 μm). Additionally, with the increased use of pre-filled syringes (PFS), particle differentiation is